Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,121 | 12,817 | 7,985 | 6,463 | 4,173 |
| Depreciation Amortization | 7,018 | 14,365 | 12,324 | 10,875 | 9,792 |
| Other Working Capital | 6,821 | 8,708 | -21,693 | -12,419 | 10,043 |
| Other Operating Activity | 11,737 | 11 | 118 | 4,409 | -987 |
| Operating Cash Flow | $28,697 | $35,901 | $-1,266 | $9,328 | $23,021 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20,615 | -37,940 | -46,526 | -58,324 | -28,683 |
| Other Investing Activity | -8,103 | 2,226 | 1,493 | 2,030 | 1,574 |
| Investing Cash Flow | $-28,718 | $-35,714 | $-45,033 | $-56,294 | $-27,109 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -12,605 | -12,002 | -9,805 | -9,063 | -6,013 |
| Other Financing Activity | 12,925 | 9,396 | 57,790 | 56,365 | 8,626 |
| Financing Cash Flow | $320 | $-2,606 | $47,985 | $47,302 | $2,613 |
| Beginning Cash Position | 330 | 2,749 | 1,063 | 727 | 2,202 |
| End Cash Position | 629 | 330 | 2,749 | 1,063 | 727 |
| Net Cash Flow | $299 | $-2,419 | $1,686 | $336 | $-1,475 |
| Free Cash Flow | |||||
| Operating Cash Flow | 28,697 | 35,901 | -1,266 | 9,328 | 23,021 |
| Free Cash Flow | 28,697 | 35,901 | -1,266 | 9,328 | 23,021 |